EPIX: ESSA Pharma Inc. - Summary | Jitta

ESSA Pharma Inc.

NASDAQ:EPIX

Notice
Stock data is unavailable or the company’s delisted.
Price
$0.20
Loss Chance
59.6%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (13)
Recent Business Performance (33)
Financial Strength (30)
Return to Shareholders (0)
Competitive Advantage (6)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 1.33% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
2.19
145.71%
3.06
135.71%
Biotechnology
5.68
37.14%
5.68
37.14%
6.13
7.38%
COMPANY DESCRIPTION
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada. As of October 9, 2025, ESSA Pharma Inc. operates as a subsidiary of Alexis Bio, Inc.